Santen
Text Size
Listen
Santen Global
  • Patients
  • Healthcare Professionals
  • Careers
  • Investors
Listen

Tap on the left to use.

  • Who We Are
    Message
    Message from the CEO
    CORE PRINCIPLE / WORLD VISION
    CORE PRINCIPLE / WORLD VISION
    VALUES
    VALUES
    History
    History of Santen
    Corporate Executives
    Top Management
    Corporate Executive
    Corporate Governance
    Corporate Governance
    Policies
    Policies and Statements
    Company Infomation
    Overview / Map
    Global Operation
  • What We Do
    Santen 2030
    Santen 2030
    Medium-term Management Plan
    Efforts to Enhance Patients' Satisfaction
    Efforts to Enhance Product Safety
    Efforts to Enhance Product Usability
    Efforts to Address Untreated Patients
    Research & Development
    Research & Development
    The Ophthalmic Product Process: R&D
    Partnering
    Santen's Partnership
    Our Partners
    Partnering Contact
    Production
    Production
    Quality Compliance
    The Ophthalmic Production Process: Production
    Sales & Marketing
    Sales & Marketing
  • Our Stories
  • Sustainability
    Sustainability at Santen
    Sustainability at Santen
    Social
    Access to Healthcare
    Research & Development in Ophthalmology
    Product Quality & Safety
    Supply Chain
    Human Rights
    Talent
    Digital Transformation (DX)
    Governance
    Corporate Governance
    Compliance
    Ethical Marketing
    Risk Management
    Environment​
    Measures against Climate Change
    Environmental Load Reduction
    Disclosures Based on the TCFD Recommendations
    Inclusion
    Inclusive Society Santen Promotes
    Santen Initiatives
    Santen Activities for Inclusive Society
    Related Information
    Participating in the UN Global Compact
    Social Contribution Activities
    Stakeholder Engagement
    Environmental Data 2022
    Employment and Human Resources Data 2022
    GRI Standards Content Index
    Sustainability Library
    External Assessment
  • News
    News
    Show All
    Press Release
    IR News
    Information
  1. HOME
  2. News
  3. 2017
  4. Press Release

2017 Press Release

RSS

Press Release

10.26.2017 Santen to Participate in UN Global Compact
09.19.2017 Santen Selected as a Member of Dow Jones Sustainability Asia Pacific Index, an Index for Socially Responsible Investment
07.26.2017 Santen Receives Positive CHMP Opinion in Europe for Ciclosporin eye drops for the Treatment of Paediatric Patients with Severe Vernal Keratoconjunctivitis
07.26.2017 Santen and TRACON Announce Initiation of a Phase 2a Study of DE-122 for the Treatment of Wet Age-Related Macular Degeneration
07.18.2017 Santen Donates to Northern Kyushu Area Disaster Relief Efforts
05.01.2017 Santen to Establish a Corporate Venture Capital Fund in the United States
03.02.2017 SANTEN AND SINGAPORE EYE RESEARCH INSTITUTE (SERI) ANNOUNCE AN EXPANDED RELATIONSHIP INCLUDING THE CREATION OF A NEW JOINT LABORATORY TO DEVELOP NOVEL OPHTHALMIC THERAPEUTICS, DIAGNOSTICS AND DEVICES
02.22.2017 Santen to Cosponsor "Light Up in Green" Campaign during World Glaucoma Week from March 12 to 18, 2017
News Archive

Official SNS

Twitter LinkedIn YouTube
  • Accessibility
  • Terms of Use
  • Privacy Policy
  • Contact
Copyright © 2023 Santen Pharmaceutical Co., Ltd.
All Rights Reserved